Proud to share that we completed our first and some of the first cases in the nation post fda approval of the Abbott VOLT Pulsed Field Ablation (PFA) system at St. Bernards Medical Center in Jonesboro, Arkansas as part of the #VOLT LMR, following VOLT’s FDA approval in late December.
What stood out in our early experience:
- Zero fluoroscopy workflow in these cases - PVI, with additional workflow as clinically needed - Very low microbubble visualization on ICE, and no clinical hemolysis observed in any of our cases
We also appreciate the platform design elements that support efficiency and precision: - Balloon-in-basket design (8 splines) that conforms to anatomy and supports targeted lesion sets - Real-time contact visualization (impedance-based) for lesion tracking - Single-catheter , zero exchange workflow enabling mapping, pacing, and ablation while minimizing catheter exchanges - The ability to customize energy delivery by selectively delivering from electrodes in good contact
Our cases were performed under general anesthesia, and it’s encouraging that PFA workflow characteristics may support future pathways that reduce reliance on GA in selected patients.
Huge thanks to our incredible St. Bernards EP Lab team and the outstanding clinical support team from @AbbottCardio. Teamwork made this LMR launch a success.
Peak frequencies (PFs) at MRAT termination sites are substantially higher than global atrial PFs, supporting the potential of PF mapping as an effective tool for identifying critical isthmuses in MRAT ablation procedures. https://t.co/FXN4O5U0Km #JACCCEP
Among patients with #AtrialFibrillation, elevated BMI, and 1 or more additional cardiometabolic risk factors, aggressive risk factor management reduced arrhythmia recurrence over the 12-month period after catheter ablation. https://t.co/2SBgFqTLei
We started our first PFA -FP zero-floro cases using the EnSite Contact Index Module to assess electrode-to-tissue distance based on impedance. This is a complementary tool to evaluate contact during PFA that seems to optimize efficacy and efficiency
🚨New findings! Thrilled to share our latest collaborative work on SVT differential diagnosis in EP studies:💡A negative SA-VA difference is a new criterion of Atrial Tachycardia! Check it out! 👇
https://t.co/K1XVB1bc3I
@Pablus_199@AranyoJulia@VictorBazanG@carloseduardogm
Safety and Effectiveness of a Novel Balloon-in-Basket Pulsed Field Ablation Catheter for the Treatment of Paroxysmal and Persistent AF: VOLT-AF IDE Trial Acute Results
#HRS2025#OpenAccess@MonicaYLo@ArHeartHospital
https://t.co/xJjOdGBwsh
Contact feedback is no April fool’s joke!
Visualize spline-by-spline contact confirmation with Contact Index software on #EnSiteX. Gray splines denote lack of contact while blue shows contact with the tissue.
Watch as fine-tuning with #Agilis13F allows for full spline participation prior to delivery.
@AbbottCardio #ContactMatters
Kicking off our PFA Technologies: Balloon-in-Basket & Dual Energy Scientific Symposium with Dr. @RolandTilz’s presentation and edited #VoltPFA live case.
#EHRA2025#AbbottProud#PFA
Safety and effectiveness of the first balloon-in-basket pulsed field ablation system for the treatment of #afib : VOLT CE Mark study 6-month results
https://t.co/TfSMrnacZi
#EHRA2025#EHRA_ESC#Europace
From ENDO⬅️ to ➡️EPI: the heart's intricate architecture. This cross section reveals the complexity of myocardial layers, essential for EP and the genesis of arrhythmias. A stunning image presented by Carlo Pappone at #EHRA2025
📰BREAKING: Our #VoltPFA System has received CE Mark in Europe!
Read the press release: https://t.co/spIHANQ3qZ
CAUTION–This product is limited by U.S. Federal Law to investigational use. Product is not approved globally and may not be available in your market.
Dual-energy ablation or balloon PFA for PVI?
The results of the SmartfIRE study (RF + PFA) and the VOLT CE Mark study (balloon PFA) will be presented in the same session at #EHRA2025! Exciting innovations ahead—stay tuned! @EHRAPresident#AFib#PFA#Electrophysiology
⚡The revolution is coming to #EHRA2025.
Get ready: https://t.co/JRspzDqHNj
CAUTION – Product is limited by U.S. Federal Law to investigational use. Product is not approved globally and may not be available in your market.